Levels of blood periostin decrease after acute myocardial infarction and are negatively associated with ventricular

Chi-Wen Cheng1, Chao-Hung Wang, Ju-Fang Lee

  • 1Heart Failure Center, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, Taoyuan, Taiwan.

Insights

Acute myocardial infarction (AMI) is linked to lower periostin (PN) levels. Lower PN concentrations after AMI predict poorer cardiac function three months later, indicating PN

Area of Science:

  • Cardiology
  • Biomarker Research
  • Regenerative Medicine

Background:

  • Periostin (PN) promotes cardiomyocyte cell cycle reentry and improves cardiac function post-AMI.
  • Previous research suggests PN's therapeutic potential in heart repair.

Purpose of the Study:

  • Investigate periostin (PN) level changes following acute myocardial infarction (AMI).
  • Determine the prognostic value of PN concentrations for cardiac function after AMI.

Main Methods:

  • Recruited 123 patients (45 AMI, 45 stable CAD, 33 controls).
  • Measured blood periostin (PN) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels.
  • Assessed cardiac function using echocardiography at 3 months post-AMI.

Main Results:

  • AMI patients exhibited significantly lower PN levels early post-event compared to CAD and control groups.
  • PN levels further decreased in AMI patients within 8-10 days.
  • Pre-discharge PN levels negatively correlated with left ventricular ejection fraction and positively with ventricular diameters at 3 months post-AMI.

Conclusions:

  • Acute myocardial infarction is associated with a significant decrease in circulating periostin levels.
  • Periostin concentrations measured before hospital discharge serve as a predictor of cardiac function recovery three months after AMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...